Transcriptional regulation of tissue factor expression in human endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 15, Issue 5, 1995, Pages 612-621

  Parry, Graham C N ^a   Mackman, Nigel ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

endothelium; gene expression; tissue factor

Indexed keywords

INTERLEUKIN 1BETA; PLASMINOGEN ACTIVATOR; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; ENDOTHELIUM CELL; ENHANCER REGION; GENE INDUCTION; HUMAN; HUMAN CELL; MICROVASCULATURE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; THROMBOGENESIS; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIUM;

EID: 0029033973     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.15.5.612     Document Type: Article

References (47)

1. Bach RR. Initiation of coagulation by tissue factor. Crit Rev Biochem. 1988;23:339-368.
2. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 1991;66:67-79.
3. Esmon CT. The regulation of natural anticoagulant pathways. Science. 1987;235:1348-1352.
4. Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties. J Biol Chem. 1989;264:20705-20713.
5. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A. 1986;83:4533-4537.
6. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984;160:618-623.
7. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest. 1987;79:124-130.
8. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest. 1983;71:1893-1896.
9. Crossman DC, Carr DP, Tuddenham EGD, Pearson JD, McVey JH. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem. 1990;265:9782-9787.
10. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988;318:1481-1486.
11. van der Poll T, Büller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJH, Hack CE, Sauerwein HP, Rosenberg RD, ten Cate JW. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med. 1990;322: 1622-1627.
12. Warr TA, Rao LVM, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood. 1990;75:1481-1489.
13. Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS. Lethal E coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 1991;33:127-134.
14. Drake TA, Cheng J, Chang A, Taylor FB Jr. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coll sepsis. Am J Pathol. 1993;142:1-13.
15. Fei H, Berliner JA, Parhami F, Drake TA. Regulation of endothelial cell tissue factor expression by minimally oxidized low density lipoprotein and lipopolysaccharide. Arterioscler Thromb. 1993;13:1711-1717.
16. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor KB binding sites. J Exp Med. 1991;174:1517-1526.
17. Abate C, Curran T. Encounters with Fos and Jun on the road to AP-1. Semin Cancer Biol. 1990;1:19-26.
18. Grilli M, Chiu JJ-S, Lenardo MJ. NF-kB and Rel: participants in a multiform transcriptional regulatory system. In: Jeon KW, Friedlander M, Jarvik J, eds. International Review of Cytology. San Diego, Calif: Academic Press Inc; 1993:1-62.
19. Oeth PA, Parry GCN, Kunsch C, Nantermet P, Rosen CA, Mackman N. LPS induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel-p65 heterodimers to a kB-like site. Mol Cell Biol. 1994;14:3772-3781.
20. Read MA, Whitley MZ, Williams AJ, Collins T. NF-kappaB and IkappaBα: an inducible regulatory system in endothelial activation. J Exp Med. 1994;179:503-512.
21. Van Mourik JA, Lawrence DA, Loskutoff DJ. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J Biol Chem. 1984;259:14914-14921.
22. Morrissey JH, Fair DS, Edgington TS. Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res. 1988;52:247-261.
23. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1982.
24. Brand K, Fowler BJ, Edgington TS, Mackman N. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol. 1991;11:4732-4738.
25. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current Protocols in Molecular Biology. New York, NY: Green Publishing Association & Wiley Interscience; 1987.
26. De Wet JR, Wood KV, Deluca M, Helinski DR, Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol. 1987;7:725-737.
27. Gorman CM, Merlino GT, Willingham MC, Pastan I, Howard BH. The rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc Natl Acad Sci U S A. 1982;79: 6777-6781.
28. Neumann JR, Morency CA, Russian KO. A novel rapid assay for chloramphenicol acetyltransferase gene expression. BioTechniques. 1987;5:444-447.
29. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA, Baldwin AS Jr. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 1992;6:1899-1913.
30. Ruben SM, Narayanan R, Klement JF, Chen C-H, Rosen CA. Functional characterization of the NF-κB p65 transcriptional activator and an alternatively spliced derivative. Mol Cell Biol. 1992;12:444-454.
31. Read MA, Cordle SR, Veach RA, Carlisle CD, Hawiger J. Cell-free pool of CD14 mediates activation of transcription factor NF-κB by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci U S A. 1993;90:9887-9891.
32. Sun S-C, Ganchi PA, Ballard DW, Greene WC. NF-kB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science. 1993;259:1912-1915.
33. Hansen SK, Baeuerle PA, Blasi F. Purification, reconstitution, and IκB association of the c-Rel-p65 (RelA) complex, a strong activator of transcription. Mol Cell Biol. 1994;14:2593-2603.
34. Cui M-Z, Parry GCN, Edgington TS, Mackman N. Regulation of tissue factor gene expression in epithelial cells: induction by serum and phorbol 12-myristate 13-acetate. Arterioscler Thromb. 1994;14:807-814.
35. Mitchell PJ, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 1989;245: 371-378.
36. Stein B, Baldwin ASJ. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-κB. Mol Cell Biol. 1993;13:7191-7198.
37. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A. 1993;90: 10193-10197.
38. Kuang AA, Novak KD, Kang S-M, Bruhn K, Lenardo MJ. Interaction between NF-κB- and serum response factor-binding elements activates an interleukin-2 receptor α-chain enhancer specifically in T lymphocytes. Mol Cell Biol. 1993;13:2536-2545.
39. Desai-Yajnik V, Samuels HH. The NF-κB and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Mol Cell Biol. 1993;13:5057-5069.
40. Stein B, Baldwin AS Jr, Ballard DW, Greene WC, Angel P, Herrlich P. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 1993;12:3879-3891.
41. Mackman N, Imes S, Maske WH, Taylor B, Lusis AJ, Drake TA. Structure of the murine tissue factor gene: chromosome location and conservation of regulatory elements in the promoter. Arterioscler Thromb. 1992;12:474-483.
42. Hofer E, Moll T, Czyz M, Holzmüller H, Bach FH. Induction of the tissue factor gene in porcine aortic endothelial cells. J Cell Biochem. 1994;(suppl 18A):323. Abstract.
43. Degitz K, Lian-Jie L, Wright Caughman S. Cloning and characterization of the 5′-transcriptional regulatory region of the human intercellular adhesion molecule 1 gene. J Biol Chem. 1991;266: 14024-14030.
44. van de Stolpe A, Caldenhoven E, Stade BG, Koenderman L, Raaijmakers JAM, Johnson JP, van der Saag PT. 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. J Biol Chem. 1994;269:6185-6192.
45. Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol. 1989;143:1366-1371.
46. Parry GCN, Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain κB-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem. 1994;269:20823-20825.
47. Cordle SR, Donald R, Read MA, Hawiger JJ. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kB proteins in human monocytic THP-1 cells. J Biol Chem. 1993;268:11803-11810.